Henrik Lajer

1.3k total citations
27 papers, 986 citations indexed

About

Henrik Lajer is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Henrik Lajer has authored 27 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 8 papers in Reproductive Medicine and 6 papers in Oncology. Recurrent topics in Henrik Lajer's work include Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cervical Cancer and HPV Research (5 papers). Henrik Lajer is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cervical Cancer and HPV Research (5 papers). Henrik Lajer collaborates with scholars based in Denmark, United States and France. Henrik Lajer's co-authors include Gedske Daugaard, Claus Høgdall, Lars Heisterberg, Danny Svane, Heine H. Hansen, Christian von Buchwald, Bodil Norrild, Marianne Hamilton Therkildsen, Christel Bræmer Lajer and Emilie Garnæs and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Henrik Lajer

26 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Lajer Denmark 16 237 236 198 197 190 27 986
Keith Y. Terada United States 19 243 1.0× 533 2.3× 530 2.7× 219 1.1× 232 1.2× 50 1.3k
Joseph T. Santoso United States 18 288 1.2× 110 0.5× 134 0.7× 92 0.5× 272 1.4× 47 920
Yong Beom Kim South Korea 19 174 0.7× 432 1.8× 368 1.9× 147 0.7× 225 1.2× 86 972
Giuseppe Scaletta Italy 20 177 0.7× 433 1.8× 499 2.5× 165 0.8× 290 1.5× 46 1.0k
Akiva P. Novetsky United States 20 282 1.2× 393 1.7× 410 2.1× 213 1.1× 221 1.2× 48 1.3k
Sumonmal Manusirivithaya Thailand 17 349 1.5× 429 1.8× 379 1.9× 91 0.5× 277 1.5× 50 976
Jens B. Knudsen Denmark 15 159 0.7× 161 0.7× 116 0.6× 68 0.3× 409 2.2× 20 810
Ragıp Atakan Al Türkiye 16 88 0.4× 303 1.3× 109 0.6× 66 0.3× 165 0.9× 56 807
Young Nam Kim South Korea 17 79 0.3× 369 1.6× 77 0.4× 146 0.7× 87 0.5× 67 792
Peter Blake United Kingdom 14 282 1.2× 219 0.9× 210 1.1× 69 0.4× 367 1.9× 21 862

Countries citing papers authored by Henrik Lajer

Since Specialization
Citations

This map shows the geographic impact of Henrik Lajer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Lajer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Lajer more than expected).

Fields of papers citing papers by Henrik Lajer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Lajer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Lajer. The network helps show where Henrik Lajer may publish in the future.

Co-authorship network of co-authors of Henrik Lajer

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Lajer. A scholar is included among the top collaborators of Henrik Lajer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Lajer. Henrik Lajer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horsbøl, Trine Allerslev, Susanne K. Kjær, Elisabeth Wreford Andersen, et al.. (2022). Use of hypnotics among women diagnosed with cervical cancer – A population-based cohort study. Gynecologic Oncology. 166(2). 300–307. 2 indexed citations
2.
Horsbøl, Trine Allerslev, Susanne Oksbjerg Dalton, Gunn Ammitzbøll, et al.. (2020). Gynaecological cancer leads to long-term sick leave and permanently reduced working ability years after diagnosis. Journal of Cancer Survivorship. 14(6). 867–877. 6 indexed citations
3.
Jensen, Pernille Tine, Tine Henrichsen Schnack, Signe Frahm Bjørn, et al.. (2020). Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer – A population-based study. European Journal of Cancer. 128. 47–56. 30 indexed citations
4.
Horsbøl, Trine Allerslev, Susanne K. Kjær, Christoffer Johansen, et al.. (2019). Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up. Gynecologic Oncology. 153(3). 625–632. 17 indexed citations
5.
6.
Zusterzeel, Petra L.M., et al.. (2019). The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma. Gynecologic Oncology. 154(2). 308–313. 21 indexed citations
7.
Mueller, Jennifer J., Henrik Lajer, Berit Jul Mosgaard, et al.. (2018). International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers. International Journal of Gynecological Cancer. 28(5). 915–924. 16 indexed citations
8.
Bjørn, Signe Frahm, Tine Henrichsen Schnack, Henrik Lajer, et al.. (2017). Classification of Ovarian Cancer Surgery FacilitatesTreatment Decisions in a GynecologicalMultidisciplinary Team. International Journal of Gynecological Cancer. 27(2). 382–389. 8 indexed citations
9.
Lajer, Henrik, Jens Hillingsø, S. Høyer, et al.. (2016). [The development of a generic guideline for multidisciplinary team conferences in Denmark].. PubMed. 178(39).
10.
Westergaard, Marie Christine Wulff, Rikke Andersen, Julie Westerlin Kjeldsen, et al.. (2016). Preclinical development of tumor-infiltrating lymphocytes (TILs) based adoptive cell transfer immunotherapy (ACT) for patients with advanced ovarian cancer. Annals of Oncology. 27. viii4–viii4. 4 indexed citations
11.
Mosgaard, Berit Jul, Mikkel Rosendahl, Tórur Dalsgaard, et al.. (2016). Robot‐assisted surgery in gynecological oncology: current status and controversies on patient benefits, cost and surgeon conditions – a systematic review. Acta Obstetricia Et Gynecologica Scandinavica. 96(3). 274–285. 24 indexed citations
12.
Mueller, Jennifer J., Claus Høgdall, Henrik Lajer, et al.. (2015). International study of primary mucinous ovarian carcinomas managed at tertiary medical centers. Gynecologic Oncology. 137. 55–56. 3 indexed citations
13.
Eriksson, Ane Gerda Zahl, Berit Jul Mosgaard, Lotte Nedergaard, et al.. (2015). An international comparison of surgically staged patients with serous and clear cell endometrial carcinoma. Gynecologic Oncology. 137. 33–33. 1 indexed citations
14.
Lajer, Henrik, Sandra Elnegaard, René dePont Christensen, et al.. (2012). Survival after stage IA endometrial cancer; can follow‐up be altered? A prospective nationwide Danish survey. Acta Obstetricia Et Gynecologica Scandinavica. 91(8). 976–982. 47 indexed citations
15.
Lajer, Christel Bræmer, Emilie Garnæs, Lennart Friis‐Hansen, et al.. (2012). The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. British Journal of Cancer. 106(9). 1526–1534. 202 indexed citations
16.
Lajer, Henrik, et al.. (2004). Magnesium and potassium homeostasis during cisplatin treatment. Cancer Chemotherapy and Pharmacology. 55(3). 231–236. 25 indexed citations
17.
Lajer, Henrik, et al.. (2003). Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. British Journal of Cancer. 89(9). 1633–1637. 30 indexed citations
18.
Lajer, Henrik, et al.. (2002). Late urologic morbidity in 177 consecutive patients after radiotherapy for cervical carcinoma: a longitudinal study. International Journal of Radiation Oncology*Biology*Physics. 54(5). 1356–1361. 6 indexed citations
19.
Lajer, Henrik, Gedske Daugaard, Anna‐Maria Andersson, & Niels E. Skakkebæk. (2002). Clinical use of serum TRA‐1‐60 as tumor marker in patients with germ cell cancer. International Journal of Cancer. 100(2). 244–246. 12 indexed citations
20.
Lajer, Henrik & Gedske Daugaard. (1999). Cisplatin and hypomagnesemia. Cancer Treatment Reviews. 25(1). 47–58. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026